Crinetics Pharmaceuticals Inc increased III. Quarter net loss per share of $-0.78 compare to net loss per share of $-0.73 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.81 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ -0.78
$
0 Mill
$-0.05
Unch.
Crinetics Pharmaceuticals Inc 's Revenue
rose by
0 % in III. Quarter (Sep 30 2022) year on year,
to $0 million and
advanced by
4.33 % sequentially.
Crinetics Pharmaceuticals Inc is Expected to report next financial results on March 29, 2023.
Crinetics Pharmaceuticals Inc 's
in III. Quarter recorded net loss of $-41.925 million, an increase from net loss of $-27.851 million in III. Quarter a year ago.
Sequentially
net loss narrowed from net loss of $-42.375 million realized in previous quarter.
